2025 annual financial data
BioNexus Gene Lab 2025 Operating margin
BioNexus Gene Lab 2025 operating margin with verified reported values.
Direct answer
Operating margin was -42.54%.
Operating income was -3,158,450 USD and net income was -2,984,607 USD.
Operating cash flow was -1,838,382 USD.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,424,911 USD
- Operating income
- -3,158,450 USD
- Net income
- -2,984,607 USD
- Operating cash flow
- -1,838,382 USD